Primary Hyperoxaluria Type III Gene HOGA1 (Formerly DHDPSL) as a Possible Risk Factor for Idiopathic Calcium Oxalate Urolithiasis
Carla G. Monico(Mayo Clinic in Arizona), Dawn S. Milliner(Mayo Clinic), Andrea G. Cogal(Mayo Clinic), Ruth Belostotsky(Shaare Zedek Medical Center), Yaacov Frishberg(Shaare Zedek Medical Center), Eric J. Bergstrahl(Mayo Clinic), Sandro Rossetti(Mayo Clinic), Julie B. Olson(VA San Diego Healthcare System), William E. Haley(Jacksonville College), Barbara M. Seide(Mayo Clinic), Hugh J. Williams(Jacksonville College), Regina M. Herges(Mayo Clinic)
Cited by 130
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years
|JAMA|2016|1.2k
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
The primary hyperoxalurias
|Kidney International|2009|373
ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling
|Journal of Clinical Investigation|2013|237